about
Fluticasone at different doses for chronic asthma in adults and childrenFluticasone versus placebo for chronic asthma in adults and childrenEffect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthmaInhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study.Non-invasive measurement of airway inflammation in asthma.Inhaled corticosteroids can reduce osteoporosis in female patients with COPDPractical guidance for the management of aromatase inhibitor-associated bone loss.Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids.Long-term therapy in COPD: any evidence of adverse effect on bone?Management of asthma in adultsBudesonide/formoterol in the treatment of asthma.Current treatment of severe asthma.Asthma medications should be available for over-the-counter use: pro.The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease.Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults.Delayed Complications and Long-Term Management of Sulfur Mustard Poisoning: A Narrative Review of Recent Advances by Iranian Researchers Part ІІ: Clinical Management and Therapy.Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
P2860
Q24241300-1FFB7745-37FD-439B-ABC8-33F9B8EEDAE3Q24241308-6DE2863D-94BF-4B79-A9D1-232637F07B3DQ28279047-35DAF82A-055F-49EE-8A02-91F6F7111A24Q34065276-126EFB6D-B1D6-48A6-9D6F-D5D1DA2E3E01Q35827816-58ECBD6B-ACDA-4C5D-9D6E-CC2B17A4B13EQ35834906-8730FB08-B164-49D0-AA1C-57528B70420EQ36585609-5F69E4C4-ED2C-4059-9A41-FC132225E978Q37109107-05259DB2-2DFA-4105-8761-7775070C4FD9Q37151578-8C090FF3-FE26-49A8-8425-388BD6EA5EB3Q37153293-73D9831F-F597-4EE7-8568-1ECE4F1CC791Q37222730-F4ADB8A4-992C-4E58-B78A-AEA3DDD607DFQ37408472-F16636B9-9094-4E9D-B232-C350EA7998D9Q37460865-339FB789-4AE3-4BB1-A953-0E8D677E5317Q37798026-127EE86C-4B3A-4F4A-A70B-F7E0D1678CFAQ37976485-FE76C897-8417-4EB6-84B4-593AE24F4067Q38223151-617D7C4A-356A-4D8A-94D9-C23D1095C2C5Q38827675-41612A5D-55E1-4B97-9B0E-5FEB1E30C64EQ42942210-810F6AC3-9FD1-4367-BC89-C2E419CFA6E4Q46486322-818AA919-5817-4D97-88EA-0D443FCD0E09Q55317148-1AE2DFA2-FF99-4B98-BA1A-E13CBB16B5A5Q56909272-F4DF7AEE-1BEB-400A-A5A3-C542A22DAAEB
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Safety of inhaled corticosteroids.
@ast
Safety of inhaled corticosteroids.
@en
type
label
Safety of inhaled corticosteroids.
@ast
Safety of inhaled corticosteroids.
@en
prefLabel
Safety of inhaled corticosteroids.
@ast
Safety of inhaled corticosteroids.
@en
P2093
P1476
Safety of inhaled corticosteroids.
@en
P2093
Anne E Tattersfield
R B Hubbard
T W Harrison
P304
P356
10.1513/PATS.200402-016MS
P577
2004-01-01T00:00:00Z